HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Venlafaxine Extended Release Tablets safely and effectively. See full prescribing information for Venlafaxine Extend

First Page		Document Content
Date: 2012-05-07 15:40:51 Psychiatry Amines Venlafaxine Serotonin-norepinephrine reuptake inhibitors Eli Lilly and Company Desvenlafaxine Serotonin–norepinephrine reuptake inhibitor Antidepressant Tramadol Chemistry Organic chemistry Alcohols		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Venlafaxine Extended Release Tablets safely and effectively. See full prescribing information for Venlafaxine Extend Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 361,34 KB Share Document on Facebook

	cymbalta and cold meds muscle pain cymbalta cymbalta samples cymbalta smell cost of cymbalta cymbalta mini mal seisures, is cymbalta a stimulant, cymbalta addiction and withdrawal DocID: 1gkay - View Document
	t i n g C o ve ra ge Sector Stock Details BSE Code DocID: 14NC8 - View Document
	Editor: Advertising: Click here to follow us on twitter.com/6_minutes DocID: 11zWQ - View Document
	Table 8(b):Significant Drugs (incl Drs Bag)-Sorted by highest volume change, year end: Jun 2009 to year end: Jun[removed]Section 85 Only Year ending Jun 2009 Rank Drug 1 Rosuvastatin 2 Desvenlafaxine Succinate DocID: 11bpo - View Document
	N022117 Asenapine Amend 3 DocID: WB4b - View Document